Tuberculosis (TB) is still a significant health concern worldwide, with millions of people dying from the disease each year.
Early and precise diagnosis is crucial for effective TB management, and ELISpot is increasingly being used for this purpose. This white paper examines the advantages of ELISpot in TB diagnosis and suggests future antigens and biomarkers that can enhance diagnostic accuracy.
Get the white paper delivered to your mailbox right away by filling out the form below!
